RDHL

RedHill Biopharma Ltd.

Company with tickers: RDHL

Market Cap

$43.80B

Shares Outstanding

50,923,261,000

CIK

1553846

CUSIP

757468301

13F Activity (30d)

2 filings 1 filers

Website

Visit website

Investor Relations

Investor relations

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-22	RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
2026-06-18	RedHill Biopharma Announces Up To $19.4 Million Private Placement
2026-06-09	RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
2026-06-08	RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
2026-06-02	RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
2026-04-30	RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
2026-04-27	RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
2026-04-22	RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
2026-02-25	Joint U.S. Commercialization of RedHill's Talicia® Commences
2026-01-05	RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
2025-12-15	RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells

Past events

Date	Event	Type
2026-06-22	BIO International Convention 2026	Event
2026-03-23	BIO-Europe Spring	Event
2026-03-05	Extraordinary General Meeting of Shareholders	Shareholder meeting
2026-03-02	BIO Investment and Growth Summit	Event
2025-11-03	BIO-EUROPE, 3 - 5th November, Vienna, Austria	Event
2025-10-08	Sachs 25th Annual Biotech in Europe Forum	Event
2025-06-16	BIO International Convention 2025	Event
2025-05-05	2025 Annual General Meeting of Shareholders	Shareholder meeting
2025-02-26	18th Annual European Life Sciences CEO Forum (Sachs_ELSF)	Event
2024-06-03	BIO International Convention 2024	Event
2024-05-31	ASCO Annual Meeting 2024	Shareholder meeting
2024-05-08	Aegis Capital Virtual Conference	Conference
2022-11-21	2nd International Conference on Microbiology & Infectious Diseases	Conference
2022-10-21	American College of Gastroenterology Annual Meeting (ACG)	Shareholder meeting
2022-09-12	H.C. Wainwright 24th Annual Global Investment Conference	Conference
2022-08-17	World Gastro 2022	Event
2022-08-07	International Conference on Emerging Infectious Diseases (ICEID)	Conference
2022-07-13	2nd ARDS Drug Development Summit	Event
2022-06-23	First Quarter 2022 Financial Results & Operational Highlights Webcast	Webcast
2022-05-24	H.C. Wainwright Global Investment Conference	Conference
2022-05-13	RedHill Biopharma Annual General Meeting of Shareholders	Shareholder meeting
2022-03-29	2022 Cantor Virtual Rare Orphan Disease Summit	Event
2022-03-28	BIO-Europe Spring 2022 Digital Conference	Conference
2022-03-17	Q4 & Full Year 2021 Financial Results Conference Call & Webcast	Conference
2022-01-10	H.C. Wainwright BioConnect Conference	Conference

Source: https://www.redhillbio.com/investors/overview/default.aspx